← Tony Greenberg

PeptideWatch: The Consumer Organization This Market Needs

The peptide market is $50B and largely unregulated. Most vendors are selling research chemicals to humans with no clinical oversight. PeptideWatch exists to change that.

What PeptideWatch Does

We audit peptide vendors on six clinical criteria: third-party testing, Certificate of Analysis availability, manufacturing standards, customer transparency, pricing integrity, and enforcement history. The results are not what the market wants to hear.

The Six-Layer Transparency Framework

Layer 1 — Source Verification: Where does the raw material come from? China? India? Domestic synthesis? The supply chain matters.

Layer 2 — Manufacturing Standards: GMP compliance, clean room standards, sterility testing. Most vendors skip this entirely.

Layer 3 — Third-Party Testing: HPLC purity testing, mass spectrometry confirmation, endotoxin testing. Non-negotiable for anything injected.

Layer 4 — Certificate of Analysis: Is the COA real? Dated? From an accredited lab? We verify.

Layer 5 — Pricing Integrity: Is the price consistent with actual manufacturing costs? Extreme discounting is a red flag.

Layer 6 — Enforcement History: FDA warning letters, FTC actions, state enforcement. We track it all.

Key Resources